Results 191 to 200 of about 5,542 (243)

Randomised, double-masked trial to compare the efficacy, safety and immunogenicity of the biosimilar aflibercept FYB203 with reference aflibercept in patients with neovascular age-related macular degeneration. [PDF]

BMJ Open Ophthalmol
Balser S, Capsius B, Hole R, Papp A, Preissinger N, Rozenknop A, Tiko T.   +6 more
europepmc   +1 more source

Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Ghosh S, Sethi B, Kalra S, Baruah MP, Mane A, Choudhari S, Petare A, Jadhav M, Patil S, Barkate H.   +9 more
europepmc   +1 more source

Regulierung und adäquate Preisbildung im Markt der Biosimilars: Projekt im Auftrag der Pfizer Deutschland GmbH

, 2017
Altin, Sibel, Bauer, Cosima, May, Uwe, Walendzik, Anke, Wasem, Jürgen, Ziebe, Anissa   +5 more
core  

Brand Manufacturer Coupons and Pharmaceutical Product Hopping.

JAMA Netw Open
Gibbons JB, DiStefano M, Anderson GF, Kesselheim AS, Socal M.   +4 more
europepmc   +1 more source

Analytical Data and Single-Dose PK are Sufficient to Conclude Comparable Immunogenicity for Biosimilars: An Ustekinumab Case Study. [PDF]

BioDrugs
Schiestl M, Roy N, Trieb M, Park JP, Guillen E, Woollett G, Wolff-Holz E.   +6 more
europepmc   +1 more source

Beyond Cost: Observations on Clinical and Patient Benefits of Biosimilars in Real-World Settings. [PDF]

BioDrugs
Kvien TK, Betteridge N, Brückmann I, Bodenmüller W, Bryn G, Danese S, Gonçalves J, Maravic Z, Thorne C, Wingate L, Cornes P.   +10 more
europepmc   +1 more source

Barriers to adoption of biosimilar insulins in Europe: A mixed-methods study. [PDF]

Diabetes Obes Metab
Car E, Habets G, Vulto AG, Heinemann L, Huys I, Simoens S.   +5 more
europepmc   +1 more source

Knowledge, Attitudes, and Practices Regarding Biosimilars Among Pharmacists and Physicians in Saudi Arabia: A Scoping Review. [PDF]

Cureus
Alanizi A, Alotaibi R, Babalghaith R, Alzahrani A, Qubaiban R, Hattan A, Alnuhait M, Al Sharif A.   +7 more
europepmc   +1 more source

Translational and real-world evidence of trastuzumab biosimilar CT-P6 plus pertuzumab in neoadjuvant HER2-positive early breast cancer. [PDF]

Breast Cancer Res Treat
Alonso-Romero JL, Martínez-García J, Carrillo-Vicente R, Aramburo AF, Díez AF, Henarejos PS, de la Morena Barrio P, Boix AP, Jiménez MD, Siles JP, Maestre JAP, de Las Heras-Rubio A, Carreño PR.   +12 more
europepmc   +1 more source

A comparison of JC virus assay performance provided with originator and biosimilar natalizumab. [PDF]

Mult Scler
Varley J, Beyrouti R, Nicholas R, Dorsey R, Brownlee W, Paling D, Mathews J, Dobson R.   +7 more
europepmc   +1 more source